Spots Global Cancer Trial Database for Induction Chemo-Nivo in Unresectable Stage III NSCLC
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Induction Chemo-Nivo in Unresectable Stage III NSCLC
Official Title: Phase II Study of Induction Platinum Doublet in Combination With Nivolumab Followed by Surgery or Concurrent Chemoradiation in Unresectable Stage IIIA-C Non-small Cell Lung Cancer (NSCLC)
Study ID: NCT06003075
Study Description
Brief Summary: The purpose of this study is to determine the response rate, safety, and effectiveness of a combination therapy in patients with lung cancer.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
University of Kentucky, Lexington, Kentucky, United States
Contact Details
Name: Ralph Zinner, MD
Affiliation: University of Kentucky
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
